The results showed that after treatment in 75 sepsis patients with ARDS (SARDS) and 75 sepsis patients without ARDS (SNARDS), the concentration of NLRP3 in serum was significantly reduced (Figure S1). This evidence concerns the gene NLRP3 and acute respiratory distress syndrome.